|
| Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Hematology
|
2017
|
NHLBI
|
NIH-17-009
|
|
IHS NARCH
|
|
|
|
$474,689
|
|
Hematology
|
2017
|
NCI
|
5R01CA158768-06
|
|
The Function of rpL5 and rpL11 in induction of p53
|
THOMAS, GEORGE
|
FUNDACIO PRIVADA INT D'VEST BIOMEDICA
|
SPAIN
|
$224,100
|
|
Hematology
|
2017
|
NHLBI
|
4R44HL106868-04
|
|
Correlating TCR diversity to immune reconstitution after cord blood transplant
|
RIEDER, MARK
|
ADAPTIVE BIOTECHNOLOGIES CORPORATION
|
WA
|
$519,759
|
|
Hematology
|
2017
|
NHLBI
|
5R44HL122028-03
|
|
Preclinical and Clinical Evaluation of Humanized NM9405
|
BANSAL, REKHA
|
NOVELMED THERAPEUTICS, INC.
|
OH
|
$1,277,607
|
|
Hematology
|
2017
|
NCI
|
5R01CA179062-03
|
|
Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy
|
SOTOMAYOR, EDUARDO
|
GEORGE WASHINGTON UNIVERSITY
|
DC
|
$362,569
|
|
Hematology
|
2017
|
NCI
|
5R01CA190789-03
|
|
Endoplasmic reticulum stress and oncoviral therapy
|
NAWROCKI, STEFFAN
|
UNIVERSITY OF ARIZONA
|
AZ
|
$316,018
|
|
Hematology
|
2017
|
NHLBI
|
4U01HL116383-04
|
|
Age of Blood in Children in Pediatric Intensive Care Units
|
SPINELLA, PHILIP
|
WASHINGTON UNIVERSITY
|
MO
|
$1,660,978
|
|
Hematology
|
2017
|
NHLBI
|
4P50HL110787-05
|
|
Notch-Mediated Expansion of Cord Blood Progenitors for Stem Cell Transplant
|
DELANEY, COLLEEN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$2,440,031
|
|
Hematology
|
2017
|
NCI
|
5R01CA181050-04
|
|
KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN
|
PULSIPHER, MICHAEL
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
CA
|
$90,772
|
|
Hematology
|
2017
|
NIAID
|
1K22AI123366-01
|
|
Mechanisms of NLRC4 inflammasome-associated hyperinflammation
|
CANNA, SCOTT
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$162,000
|
|
Hematology
|
2017
|
NCI
|
5R21CA187412-03
|
|
Impact of primary tumor development stage on prognosis and outcome in B-ALL
|
CARLSON, CHRISTOPHER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$100,931
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL111111-06
|
|
Altering Sedation Paradigms to Improve Brain Injury and Survival in Severe Sepsis
|
PANDHARIPANDE, PRATIK
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$740,946
|
|
Hematology
|
2017
|
NIEHS
|
5U13ES026496-02
|
|
Childhood Leukemia International Consortium Scientific Annual Meetings
|
METAYER, CATHERINE
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$15,000
|
|
Hematology
|
2017
|
NICHD
|
1R43HD085600-01A1
|
|
Development of bioactive surface for pediatric hemodialysis catheters to prevent thrombogenic, inflammatory and biofilm complications
|
HUSSAIN, ALI
|
ENSION, INC.
|
PA
|
$299,832
|
|
Hematology
|
2017
|
NHLBI
|
5R44HL118907-03
|
|
Small blood pumps for small patients
|
SNYDER, TREVOR
|
VADOVATIONS, INC.
|
OK
|
$3,007,461
|
|
Hematology
|
2017
|
NCI
|
1P01CA193124-01A1
|
8756
|
Project 3: Fanconi Anemia and Repair of DNA-Protein Crosslinks
|
LI, LEI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$326,789
|
|
Hematology
|
2017
|
NCI
|
1K22CA207598-01
|
|
The Role of Suv420h1 Histone Methyltransferase in MYC-Driven Tumorigenesis
|
LI, YULIN
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
TX
|
$188,379
|
|
Hematology
|
2017
|
NIAID
|
5R01AI110618-03
|
|
Pneumococcal pathogenesis in sickle cell disease
|
ROSCH, JASON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$445,000
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL077213-12
|
|
Pathophysiological Activities of of Oxidized Phospholipids
|
PODREZ, EUGENE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$356,625
|
|
Hematology
|
2017
|
NIAID
|
5R01AI105114-04
|
|
Viral Interface with an Interferon-Induced Gene
|
REICH, NANCY
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$463,541
|
|
Hematology
|
2017
|
NIAID
|
5R01AI079243-09
|
|
MicroRNA Function in the Immune System
|
BALTIMORE, DAVID
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
CA
|
$416,250
|
|
Hematology
|
2017
|
NIAID
|
5R01AI072194-08
|
|
Elucidation of Immunoglobulin Class Switch Recombination
|
CHAUDHURI, JAYANTA
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$439,750
|
|
Hematology
|
2017
|
NIAID
|
5R01AI114556-03
|
|
Targeting Fnip1 to disrupt B cell development, metabolism, and transformation
|
IRITANI, BRIAN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$386,250
|
|
Hematology
|
2017
|
NIAID
|
5R01AI097320-05
|
|
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID
|
PORTEUS, MATTHEW
|
STANFORD UNIVERSITY
|
CA
|
$394,389
|
|
Hematology
|
2017
|
NIAID
|
5K23AI114994-03
|
|
Rapid Identification of Neutropenic Patients at High Risk of CRE Bacteremia
|
SATLIN, MICHAEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$191,015
|
|
Hematology
|
2017
|
NHLBI
|
5F31HL126462-02
|
|
The Role of Long Noncoding RNAs in HbF Variance in Induced Pluripotent Stem Cell-Derived Erythroid Cells from Patients with Sickle Cell Anemia
|
MORRISON, TASHA
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$28,044
|
|
Hematology
|
2017
|
NIAID
|
5R01AI105129-04
|
|
Contribution of LukED to Staphylococcus aureus pathobiology
|
TORRES, VICTOR
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$426,100
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL124209-03
|
|
Defining the roles of RIPK1 and RIPK3 in emergency hematopoiesis
|
CROKER, BEN
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$442,500
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL123605-04
|
|
The Mechanism of Shear-Induced Release and Activation of TGF-beta1
|
AHAMED, JASIMUDDIN
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$428,750
|
|
Hematology
|
2017
|
NIAID
|
5R01AI120625-02
|
|
Molecular Regulation of Systemic Inflammation
|
STEHLIK, CHRISTIAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$386,250
|
|
Hematology
|
2017
|
NCI
|
5R00CA154880-06
|
|
The role of AF10 in normal and leukemic hematopoiesis
|
DESHPANDE, ANIRUDDHA
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
|
CA
|
$248,999
|
|
Hematology
|
2017
|
NCI
|
5R01CA132640-16
|
|
Role of heat shock factors (Hsfs) in tumorigenesis
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
GA
|
$270,000
|
|
Hematology
|
2017
|
NIAID
|
5R01AI104841-04
|
|
Propargyl-linked Antifolates Targeting Klebsiella pneumoniae
|
WRIGHT, DENNIS
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$696,770
|
|
Hematology
|
2017
|
NCI
|
5R01CA055349-23
|
|
Mechanisms of action of a TCR-like antibody to WT1
|
SCHEINBERG, DAVID
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$384,667
|
|
Hematology
|
2017
|
NIAID
|
5R01AI116629-02
|
|
Use of Biomimicry to Determine the Effect of Sepsis on Neutrophil Traction
|
REICHNER, JONATHAN
|
RHODE ISLAND HOSPITAL
|
RI
|
$408,754
|
|
Hematology
|
2017
|
NIAID
|
5R01AI033993-23
|
|
Processed Antigen Characterization by Mass Spectrometry
|
HUNT, DONALD
|
UNIVERSITY OF VIRGINIA
|
VA
|
$615,162
|
|
Hematology
|
2017
|
NIAID
|
5R01AI110937-03
|
|
Molecular basis and intervention of Staphylococcus aureus agglutination
|
MISSIAKAS, DOMINIQUE
|
UNIVERSITY OF CHICAGO
|
IL
|
$389,432
|
|
Hematology
|
2017
|
NIAID
|
5R01AI121804-02
|
|
Molecular mechanism of Mincle mediated NET formation:Implications for pneumonic sepsis
|
SHARMA, JYOTIKA
|
UNIVERSITY OF NORTH DAKOTA
|
ND
|
$347,500
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL125339-03
|
|
Nano-agent for photoacoustic theranostics of dialysis graft/fistula occlusions
|
POZZO, LILO
|
UNIVERSITY OF WASHINGTON
|
WA
|
$573,265
|
|
Hematology
|
2017
|
NCI
|
5R01CA184187-03
|
|
DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations
|
ZHA, SHAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$366,000
|
|
Hematology
|
2017
|
NCI
|
5R01CA190964-03
|
|
Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$544,106
|
|
Hematology
|
2017
|
NCI
|
5R21CA201453-02
|
|
Hyperpolarized arginine imaging of inflammatory cells and their inhibition in GBM
|
RONEN, SABRINA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$172,369
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL122216-03
|
|
Inducing NK cells to remember and fight cancer
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
MN
|
$382,057
|
|
Hematology
|
2017
|
NIAID
|
5R01AI111095-03
|
|
HBGA receptors in host cell entry and infection of norovirus
|
JIANG, WEN
|
PURDUE UNIVERSITY
|
IN
|
$489,779
|
|
Hematology
|
2017
|
NIAID
|
5R01AI114557-03
|
|
Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$593,287
|
|
Hematology
|
2017
|
NIAID
|
5R01AI051390-16
|
|
Immunology of factor IX gene transfer to liver
|
HERZOG, ROLAND
|
UNIVERSITY OF FLORIDA
|
FL
|
$337,500
|
|
Hematology
|
2017
|
NIAID
|
5R21AI121644-02
|
|
Development of the RNA molecule-enriched, cell type-specific exosomes
|
JIN, YANG
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$222,075
|
|
Hematology
|
2017
|
NIAID
|
5K23AI115001-04
|
|
BLOCKING AUTOANTIBODY SECRETION IN CVID PATIENTS WITH ITP BY IL-2 RESTORED TREGS
|
ROMBERG, NEIL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$186,408
|
|
Hematology
|
2017
|
NCI
|
5R01CA191077-03
|
|
Assay Development for NSD1 Methyltransferase Inhibitor Discovery
|
KOLB, EDWARD
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
DE
|
$312,244
|
|
Hematology
|
2017
|
NCI
|
5R21CA195356-02
|
|
Role of ThPOK in HSC Maintenance and Leukemogenesis
|
KAPPES, DIETMAR
|
RESEARCH INST OF FOX CHASE CAN CTR
|
PA
|
$199,013
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM111741-03
|
|
High-throughput informatics for antibodies
|
MACCARTHY, THOMAS
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$266,488
|
|
Hematology
|
2017
|
NHLBI
|
5K08HL125806-03
|
|
IL-1beta in the Development of Hypoxemia in Acute Lung Injury
|
JONES, HEATHER
|
CEDARS-SINAI MEDICAL CENTER
|
CA
|
$171,072
|
|
Hematology
|
2017
|
NIMHD
|
5T37MD008639-04
|
|
HEALTH DISPARITIES RESEARCH THROUGH INTERNATIONAL EXCHANGE
|
ANDERSON, WINSTON
|
HOWARD UNIVERSITY
|
DC
|
$255,919
|
|
Hematology
|
2017
|
NCI
|
5R21CA194829-03
|
|
Metabolic regulation of T-ALL cellular proliferation and lifespan
|
RATHMELL, JEFFREY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$204,885
|
|
Hematology
|
2017
|
NIDCR
|
5R01DE025567-02
|
|
Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid
|
ZHOU, Z
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$385,000
|
|
Hematology
|
2017
|
NCI
|
5F31CA183569-04
|
|
The Role of ATF4 in Promoting c-Myc Induced Lymphomagenesis
|
TAMEIRE, FEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$30,934
|
|
Hematology
|
2017
|
NCI
|
5K08CA184420-04
|
|
Sequence-based pathogen discovery in post-stem cell transplantation syndromes
|
BHATT, AMI
|
STANFORD UNIVERSITY
|
CA
|
$173,448
|
|
Hematology
|
2017
|
NCI
|
1R35CA197594-01A1
|
|
Synergistic role of signaling and epigenetics in leukemic transformation
|
LEVINE, ROSS
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$1,028,400
|
|
Hematology
|
2017
|
NCI
|
1R35CA197695-01A1
|
|
Translating genomic discoveries to improved outcomes for high risk acute leukemia
|
MULLIGHAN, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$1,071,276
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM113832-03
|
|
Synthetic HDL_a potential sepsis therapy
|
LI, XIANG-AN
|
UNIVERSITY OF KENTUCKY
|
KY
|
$603,893
|
|
Hematology
|
2017
|
NIAID
|
5R01AI121401-02
|
|
Multiple B. burgdorferi Factors Collaborate to Evade Complement-Mediated Defenses
|
LEONG, JOHN
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$629,219
|
|
Hematology
|
2017
|
NCI
|
5R01CA175313-04
|
|
The Role of MMP13 in Multiple Myeloma Bone Disease
|
LENTZSCH, SUZANNE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$331,098
|
|
Hematology
|
2017
|
NCI
|
5R01CA178393-02
|
|
Genomic Architecture of LGL Leukemia
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
VA
|
$609,457
|
|
Hematology
|
2017
|
NCI
|
5R01CA190688-02
|
|
SON-mediated gene expression and leukemia
|
AHN, ERIN
|
UNIVERSITY OF SOUTH ALABAMA
|
AL
|
$346,556
|
|
Hematology
|
2017
|
NCI
|
5R01CA193981-02
|
|
KLF9-dependent pathways in multiple myeloma drug resistance
|
NIKIFOROV, MIKHAIL
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$392,306
|
|
Hematology
|
2017
|
NCI
|
5R01CA194090-02
|
|
Treatment of multiple myeloma using oncolytic myxoma virus
|
BARTEE, ERIC
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$341,981
|
|
Hematology
|
2017
|
NCI
|
5R01CA195519-02
|
|
Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
CA
|
$272,213
|
|
Hematology
|
2017
|
NHLBI
|
5K25HL121192-04
|
|
MRI-based Quantitative Brain Perfusion Mapping for Sickle Cell Disease
|
QIN, QIN
|
HUGO W. MOSER RES INST KENNEDY KRIEGER
|
MD
|
$176,411
|
|
Hematology
|
2017
|
NCI
|
7R01CA175349-04
|
|
MOLECULAR TARGETS OF TRANSLOCATION T(4;14) IN MULTIPLE MYELOMA PATHOGENESIS
|
TOMASSON, MICHAEL
|
UNIVERSITY OF IOWA
|
IA
|
$309,622
|
|
Hematology
|
2017
|
NCI
|
5R01CA182461-04
|
|
Defining the impact of clonal evolution on chronic lymphocytic leukemia
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
MA
|
$362,378
|
|
Hematology
|
2017
|
NCI
|
5R01CA077544-16
|
|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
CA
|
$539,228
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK103854-02
|
|
U2AF1 mutations in myelodysplastic syndromes: from mechanism to therapy
|
BRADLEY, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$399,113
|
|
Hematology
|
2017
|
NICHD
|
5UG1HD049983-13
|
|
Renewal Application for the Childrens Hospital of Pittsburgh Collaborative Pediatric Critical Care Research Network Site
|
CARCILLO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$264,880
|
|
Hematology
|
2017
|
NHLBI
|
5T32HL007910-18
|
|
Basic Sciences Studies on Gene Therapy of Blood Diseases
|
BROXMEYER, HAL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$430,810
|
|
Hematology
|
2017
|
NCI
|
5R01CA201184-02
|
|
Biologic and Therapeutic Significance of miR-155 in AML
|
MARCUCCI, GUIDO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
CA
|
$554,107
|
|
Hematology
|
2017
|
NHLBI
|
5K23HL119557-03
|
|
Improving Pain in Sickle Cell Patients With Targeted Antithrombotic Therapy
|
SHAH, NIRMISH
|
DUKE UNIVERSITY
|
NC
|
$157,929
|
|
Hematology
|
2017
|
NCI
|
5R01CA072669-20
|
|
Cytotoxic-T-Lymphocyte (CTL) Therapy of AML
|
BLAZAR, BRUCE
|
UNIVERSITY OF MINNESOTA
|
MN
|
$294,076
|
|
Hematology
|
2017
|
NCI
|
5R01CA201719-02
|
|
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
CA
|
$361,504
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK107716-02
|
|
Regulation of the telomerase RNA component in hematopoiesis
|
AGARWAL, SUNEET
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$398,250
|
|
Hematology
|
2017
|
NHLBI
|
5F32HL124947-03
|
|
Neural regulation of the hematopoietic stem cell niche
|
MURPHY, MALEA
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$58,002
|
|
Hematology
|
2017
|
NINDS
|
5R01NS087147-03
|
|
Vascular Ectonucleotidase Regulation of Ischemic Stroke
|
PINSKY, DAVID
|
UNIVERSITY OF MICHIGAN
|
MI
|
$421,547
|
|
Hematology
|
2017
|
NCI
|
5R01CA167289-05
|
|
Mechanism of action of Prdm16 in hematopoietic stem cells
|
SNOECK, HANS-WILLEM
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$332,000
|
|
Hematology
|
2017
|
NIAID
|
5R01AI101256-03
|
|
Structural and Biochemical Studies of Jak2
|
HUBBARD, STEVAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$423,750
|
|
Hematology
|
2017
|
NCI
|
5R01CA164178-05
|
|
A novel NKG2D-specific BiTE cancer immunotherapy
|
SENTMAN, CHARLES
|
DARTMOUTH COLLEGE
|
NH
|
$336,150
|
|
Hematology
|
2017
|
NIAID
|
5R01AI117229-03
|
|
miR-29b and autophagy regulate alveolar macrophage function post-BMT
|
MOORE, BETHANY
|
UNIVERSITY OF MICHIGAN
|
MI
|
$426,373
|
|
Hematology
|
2017
|
NCI
|
5R01CA169784-04
|
|
Genetic Dissection of Acute Myeloid Leukemia.
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$355,993
|
|
Hematology
|
2017
|
NCI
|
5R01CA172408-04
|
|
Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies
|
YANG, FENG-CHUN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$318,513
|
|
Hematology
|
2017
|
NCI
|
5R01CA174683-04
|
|
Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia
|
BHATIA, SMITA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$606,475
|
|
Hematology
|
2017
|
NCI
|
5R01CA190635-03
|
|
Genetic Framework and Molecular Mechanism of Fanconi Anemia
|
LI, LEI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$366,000
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK107413-02
|
|
Mesenchymal Stromal Cells Regulate Hematopoietic Stem Cell Aging
|
NAKADA, DAISUKE
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$431,329
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL125089-03
|
|
EHR Anticoagulants Pharmacovigilance
|
YU, HONG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$1,177,432
|
|
Hematology
|
2017
|
NCI
|
5R01CA167511-05
|
|
Translation of Novel Therapeutic Targets in Multiple Myeloma
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
AZ
|
$431,907
|
|
Hematology
|
2017
|
NIA
|
5R01AG049074-04
|
|
Dissecting the aging of hematopoietic stem cells by genetic tracing in vivo
|
REIZIS, BORIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$347,475
|
|
Hematology
|
2017
|
NCI
|
5R03CA191443-02
|
|
Molecular Mechanisms of Chromosomal Segregation by Epigenetic Regulators
|
REN, XIAOJUN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$77,750
|
|
Hematology
|
2017
|
NCI
|
5R01CA193523-02
|
|
Systematic Light Exposure for Fatigue in Stem Cell Transplant Survivors
|
REDD, WILLIAM
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$690,812
|
|
Hematology
|
2017
|
NCI
|
5R01CA182528-05
|
|
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
|
CHEN, JIANJUN
|
UNIVERSITY OF CINCINNATI
|
OH
|
$336,114
|
|
Hematology
|
2017
|
NIAID
|
5R37AI063331-12
|
|
Cryopyrin/NLRP3 Signaling in Inflammation and Innate Immunity
|
NUNEZ, GABRIEL
|
UNIVERSITY OF MICHIGAN
|
MI
|
$387,500
|
|
Hematology
|
2017
|
NIEHS
|
5R01ES025409-02
|
|
Defining the Role of the AHR in Blood Cell Specifications
|
SHERR, DAVID
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$359,656
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM113894-02
|
|
Mechanisms of Temperature Regulation
|
CONTI, BRUNO
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$385,000
|
|
Hematology
|
2017
|
NIAID
|
5R01AI106393-05
|
|
BH3-only protein targeting by HHV-8
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$405,000
|
|
Hematology
|
2017
|
NCI
|
5R00CA181500-04
|
|
The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development
|
BLACKBURN, JESSICA
|
UNIVERSITY OF KENTUCKY
|
KY
|
$248,999
|
|
Hematology
|
2017
|
NCI
|
5F31CA192835-03
|
|
Intratumoral Heterogeneity and Tumor Evolution in Lymphoma
|
KASTENHUBER, EDWARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$44,044
|
|
Hematology
|
2017
|
NINDS
|
5R01NS027713-26
|
|
Hemodynamics of Cerebral Arteriovenous Malformations
|
SU, HUA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$313,082
|
|
Hematology
|
2017
|
NCI
|
5F31CA196330-02
|
|
Investigating the potential role of NADPH oxidase 2 in regulating the biology of leukemic stem cells
|
ADANE, BINIAM
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$29,728
|
|
Hematology
|
2017
|
NIAID
|
5R01AI113320-03
|
|
Mechanisms regulating the B lymphopoiesis fetal/adult switch
|
HAYAKAWA, KYOKO
|
RESEARCH INST OF FOX CHASE CAN CTR
|
PA
|
$457,500
|
|
Hematology
|
2017
|
NCI
|
5R01CA195688-02
|
|
Mutations that Distinguish Benign from Malignant Plasma Cell Neoplasams
|
BERGSAGEL, PETER
|
MAYO CLINIC ARIZONA
|
AZ
|
$379,725
|
|
Hematology
|
2017
|
NIEHS
|
5R21ES025329-02
|
|
Replication fork reestablishment across a DNA interstrand crosslink
|
MORIYA, MASAAKI
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$197,500
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM114473-03
|
|
Contribution of Cholesterol Homeostasis for Injury Resolution
|
DE MAIO, ANTONIO
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$294,500
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL117976-04
|
|
Epithelial mechanisms of inducible resistance to AML-associated pneumonia
|
EVANS, SCOTT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$400,000
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM073857-10
|
|
Mechanism and Uses of Transmembrane Helix Insertion by Soluble Peptides
|
ENGELMAN, DONALD
|
YALE UNIVERSITY
|
CT
|
$569,403
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL130353-02
|
|
Sequential release of IL-1alpha and IL-1beta leads to a two-hit model of acute lung injury
|
SHIMADA, KENICHI
|
CEDARS-SINAI MEDICAL CENTER
|
CA
|
$437,500
|
|
Hematology
|
2017
|
NCI
|
5R01CA167708-05
|
|
Targeting AML with PI3K/AKT inhibitors and BH3-mimetics
|
GRANT, STEVEN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$284,794
|
|
Hematology
|
2017
|
NIAID
|
5R01AI110985-03
|
|
Regulation of Hematopoiesis by Ribosomal Protein Paralogs
|
WIEST, DAVID
|
RESEARCH INST OF FOX CHASE CAN CTR
|
PA
|
$453,613
|
|
Hematology
|
2017
|
NIAID
|
5R01AI108407-03
|
|
Role of MHV68 miRNAs in latencyand pathogenesis
|
TIBBETTS, SCOTT
|
UNIVERSITY OF FLORIDA
|
FL
|
$396,236
|
|
Hematology
|
2017
|
NCI
|
5R01CA194058-02
|
|
Painted erythrocyte carriers for therapy of acute myeloid leukemia
|
SIMBERG, DIMITRI
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$352,151
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM112930-03
|
|
Duplex miR-223 and Exosomes in Sepsis
|
FAN, GUOCHANG
|
UNIVERSITY OF CINCINNATI
|
OH
|
$300,030
|
|
Hematology
|
2017
|
NIAID
|
5R01AI042792-17
|
|
Tick Mammal Interface of Human Granulocytic Anaplasmosis
|
MUNDERLOH, ULRIKE
|
UNIVERSITY OF MINNESOTA
|
MN
|
$639,006
|
|
Hematology
|
2017
|
NCI
|
5R01CA185301-03
|
|
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
OH
|
$352,275
|
|
Hematology
|
2017
|
NCI
|
5R01CA201230-02
|
|
The role of H3K79 methylation in IDH-mutant leukemia
|
BERNT, KATHRIN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$10,000
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK048252-23
|
|
Transgene Persistence in Liver Gene Therapy
|
GROMPE, MARKUS
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$368,829
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM113816-03
|
|
Role of erythroid DAMP molecules in the pathogenesis of vascular injury in sepsis
|
ZUCKERBRAUN, BRIAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$668,614
|
|
Hematology
|
2017
|
NCI
|
5R01CA090668-14
|
|
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia
|
SMALL, DONALD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$291,600
|
|
Hematology
|
2017
|
NCI
|
5R01CA183444-04
|
|
Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies
|
BYRD, JOHN
|
OHIO STATE UNIVERSITY
|
OH
|
$523,187
|
|
Hematology
|
2017
|
NCI
|
5R01CA190372-03
|
|
Molecular mechanisms of myeloid suppressor genes on chromosome 5
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
IL
|
$361,425
|
|
Hematology
|
2017
|
NCI
|
5R01CA142665-07
|
|
Glucocorticoids in Lymphoblastic Leukemia
|
RELLING, MARY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$487,994
|
|
Hematology
|
2017
|
NCI
|
5R21CA200420-02
|
|
The effect of statins on B cell dysfunction in HIV infection
|
MARTINEZ-MAZA, OTONIEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$215,985
|
|
Hematology
|
2017
|
NIAID
|
5R01AI111205-03
|
|
Multivalent Toxoid Vaccine for Prevention of S. aureus Invasive Diseases
|
AMAN, M.
|
INTEGRATED BIOTHERAPEUTICS, INC.
|
MD
|
$758,111
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK104814-02
|
|
Cdc42, hematopoietic stem cell polarity, and cell fate
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$496,716
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM117093-02
|
|
Kinase-mediated assembly of the mRNA entry channel in 40S ribosomes
|
KARBSTEIN, KATRIN
|
SCRIPPS FLORIDA
|
FL
|
$416,481
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL124015-02
|
|
Latexin function in the maintenance and regeneration of the hematopoietic system
|
LIANG, YING
|
UNIVERSITY OF KENTUCKY
|
KY
|
$376,250
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL067395-15
|
|
Genetic Dissection of Drosophila Hematopoiesis
|
BANERJEE, UTPAL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$376,790
|
|
Hematology
|
2017
|
NIAID
|
5R21AI122670-02
|
|
Developing a new model for EBV-mediated T cell diseases
|
PELANDA, ROBERTA
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$233,250
|
|
Hematology
|
2017
|
NCI
|
5R01CA172492-05
|
|
Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma
|
PASQUALUCCI, LAURA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$332,000
|
|
Hematology
|
2017
|
NICHD
|
5K23HD070972-05
|
|
Postpartum Hemmorrhage and Anemia: Epidemiologic and Cost-Effectiveness Analyses
|
BUTWICK, ALEXANDER
|
STANFORD UNIVERSITY
|
CA
|
$168,156
|
|
Hematology
|
2017
|
NIAID
|
5R21AI121689-02
|
|
Development of therapeutic bacteriophages against carbapenemase-resistant Klebsiella pneumoniae
|
GILL, JASON
|
TEXAS A&M AGRILIFE RESEARCH
|
TX
|
$235,888
|
|
Hematology
|
2017
|
NCI
|
5R01CA080728-17
|
|
Dissection of eIF4E dependent mRNA export
|
BORDEN, KATHERINE
|
UNIVERSITY OF MONTREAL
|
CANADA
|
$210,799
|
|
Hematology
|
2017
|
NIAID
|
5R37AI037526-23
|
|
Class Switch Recombination in B Lymphocytes
|
NUSSENZWEIG, MICHEL
|
ROCKEFELLER UNIVERSITY
|
NY
|
$423,750
|
|
Hematology
|
2017
|
NCI
|
5K08CA181340-04
|
|
Targeting Chromatin Modifications in Leukemia with Trisomy 21
|
LANE, ANDREW
|
DANA-FARBER CANCER INST
|
MA
|
$155,991
|
|
Hematology
|
2017
|
NCI
|
5R01CA184464-03
|
|
Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma
|
ORLOWSKI, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$356,280
|
|
Hematology
|
2017
|
NCI
|
5R01CA192844-02
|
|
The Role of CD86 in Multiple Myeloma
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
GA
|
$348,359
|
|
Hematology
|
2017
|
NCI
|
5P30CA014236-43
|
5330
|
Hematologic Malignancies and Cellular Therapies Research Program
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
NC
|
$41,908
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK107784-02
|
|
Deconvoluting the hematopoietic niche under stress
|
SCADDEN, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$514,508
|
|
Hematology
|
2017
|
NHLBI
|
5F31HL126338-03
|
|
Identifying factors that promote clonal dominance in zebrafish hematopoiesis
|
HENNINGER, JONATHAN
|
HARVARD MEDICAL SCHOOL
|
MA
|
$31,581
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL126850-02
|
|
Novel factor VIII variants for improved efficacy in gene therapy for hemophilia A
|
SABATINO, DENISE
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$420,000
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL130034-02
|
|
The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML
|
FRIEDMAN, ALAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$405,000
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL122774-03
|
|
Cell type-specific influences on HHT pathogenesis
|
SU, HUA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$397,607
|
|
Hematology
|
2017
|
NIAID
|
5R21AI119929-02
|
|
Neonatal Antibiotic Therapy, The Pulmonary Microbiome, and theCholinergic Anti-inflammatory Pathway
|
PHILLIPS, JOY
|
SAN DIEGO STATE UNIVERSITY
|
CA
|
$225,375
|
|
Hematology
|
2017
|
NICHD
|
1R21HD088005-01A1
|
|
Antibiotic Effects on the Developing Microbiome Metabolome and Morbidites in Preterm Neonates.
|
NEU, JOSEF
|
UNIVERSITY OF FLORIDA
|
FL
|
$228,750
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL117722-03
|
|
Platelet and coagulation activation in response to vascular injury
|
RUGGERI, ZAVERIO
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$587,350
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL112614-05
|
|
Comparative Effectiveness in the Diagnosis of VWD
|
MONTGOMERY, ROBERT
|
BLOODCENTER OF WISCONSIN, INC.
|
WI
|
$817,579
|
|
Hematology
|
2017
|
NCI
|
5R00CA183914-04
|
|
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
|
WAN, LIXIN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$254,171
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL126810-02
|
|
Mechanism of Type 4 Collagen Interactions with Von Willebrand Factor
|
FLOOD, VERONICA
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$371,303
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL130414-02
|
|
Nonsense Readthrough: a Therapeutic Approach to Inherited Vascular Disorders
|
ALDRED, MICHEALA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$396,250
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL130871-02
|
|
Development of highly efficient factor VIII mini-gene therapy
|
XIAO, WEIDONG
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$487,271
|
|
Hematology
|
2017
|
RMAP
|
5R01HL117329-06
|
|
Eliminating Mediators of Toxicity from Stored Blood
|
SHEVKOPLYAS, SERGEY
|
UNIVERSITY OF HOUSTON
|
TX
|
$376,250
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL130054-02
|
|
Generation of alloantigen-specific Designer Platelets for diagnostic and investigative use
|
NEWMAN, PETER
|
BLOODCENTER OF WISCONSIN, INC.
|
WI
|
$510,464
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL052246-23
|
|
Structure and Function of Protein C
|
GRIFFIN, JOHN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$653,965
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL130446-02
|
|
ALLOSTERIC REGULATION OF ADAMTS13
|
SADLER, J
|
WASHINGTON UNIVERSITY
|
MO
|
$421,685
|
|
Hematology
|
2017
|
NCI
|
5R01CA196266-02
|
|
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$502,591
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK104028-02
|
|
Defining Nfix's role as a novel key regulator of hematopoietic stem cells
|
MCKINNEY-FREEMAN, SHANNON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$403,875
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL056067-21
|
|
T-Cell Targeting for GVHD
|
BLAZAR, BRUCE
|
UNIVERSITY OF MINNESOTA
|
MN
|
$381,812
|
|
Hematology
|
2017
|
NCI
|
5R01CA190384-03
|
|
The genomic pathogenesis of Follicular Lymphoma
|
MALEK, SAMI
|
UNIVERSITY OF MICHIGAN
|
MI
|
$541,994
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL095675-08
|
|
Lnk Regulatory Functions in Hematopoietic Stem Cells
|
TONG, WEI
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$419,449
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM083016-08
|
|
Innate Immunity and Cardiovascular Function in Sepsis
|
LI, CHUANFU
|
EAST TENNESSEE STATE UNIVERSITY
|
TN
|
$306,600
|
|
Hematology
|
2017
|
NIGMS
|
5K23GM113041-03
|
|
Platelet activation in septic shock
|
PUSKARICH, MICHAEL
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
MS
|
$189,752
|
|
Hematology
|
2017
|
NIBIB
|
5R21EB020424-02
|
|
Microfluidic assays for hyper-reactive platelets in diabetes
|
LU, HANG
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
GA
|
$228,032
|
|
Hematology
|
2017
|
NCI
|
5R01CA194263-02
|
|
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
|
FANG, CAROLYN
|
RESEARCH INST OF FOX CHASE CAN CTR
|
PA
|
$632,188
|
|
Hematology
|
2017
|
NCI
|
5R01CA180758-04
|
|
KSHV interactions with host inflammasome components
|
CHANDRAN, BALA
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
IL
|
$63,355
|
|
Hematology
|
2017
|
NCI
|
5P01CA094237-15
|
7520
|
VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$295,519
|
|
Hematology
|
2017
|
NCI
|
5K22CA184308-03
|
|
Dissecting Genetic and Epigenetic variation in the Cancer Regulome
|
HODGES, EMILY
|
VANDERBILT UNIVERSITY
|
TN
|
$157,854
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL077671-12
|
|
Endothelial Toll-Like Receptor Signaling and Inflammation
|
ZHU, WEIQUAN
|
UNIVERSITY OF UTAH
|
UT
|
$372,500
|
|
Hematology
|
2017
|
NIAID
|
5R21AI124172-02
|
|
Rab7 and NF-kappaB in B cell activation and dysregulation
|
XU, ZHENMING
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$187,213
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL125886-03
|
|
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin
|
GLADWIN, MARK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$582,028
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL121134-04
|
|
Drug delivery by carrier erythrocytes
|
MUZYKANTOV, VLADIMIR
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$657,458
|
|
Hematology
|
2017
|
NCI
|
5P30CA008748-51
|
7551
|
Monoclonal Antibody
|
WEIS-GARCIA, FRANCES
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$308,192
|
|
Hematology
|
2017
|
NCI
|
5R01CA194264-02
|
|
Proteasome Assembly Chaperones in Sensitivity and Resistance to Proteasome Inhibitors
|
ORLOWSKI, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$359,851
|
|
Hematology
|
2017
|
NCI
|
5F30CA183507-04
|
|
Cytotoxicity of MLN4924 in Acute Myeloid Leukemia
|
KNORR, KATHERINE
|
MAYO CLINIC ROCHESTER
|
MN
|
$23,878
|
|
Hematology
|
2017
|
NCI
|
5R01CA172398-05
|
|
The role of ETV6 in T-cell acute lymphoblastic leukemia
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$332,000
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK104920-02
|
|
Elucidation of the role of Setd8 and H4K20me1 in Erythropoiesis
|
STEINER, LAURIE
|
UNIVERSITY OF ROCHESTER
|
NY
|
$345,938
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM114180-03
|
|
Dopaminergic regulation of the immune system
|
ULLOA, LUIS
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
NJ
|
$302,100
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL068835-11
|
|
Characterization of an isoform specific anticoagulant function of TFPI-alpha
|
MAST, ALAN
|
BLOODCENTER OF WISCONSIN, INC.
|
WI
|
$422,194
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL121264-04
|
|
Endothelialized microfluidics for sickle cell disease research & drug discovery
|
LAM, WILBUR
|
EMORY UNIVERSITY
|
GA
|
$390,164
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL127041-02
|
|
Functional Dynamics of Thrombin
|
KOMIVES, ELIZABETH
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$363,720
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL130472-02
|
|
Pathogenesis of ELANE-Associated Neutropenia
|
HORWITZ, MARSHALL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$435,000
|
|
Hematology
|
2017
|
NCI
|
5R01CA165469-05
|
|
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia
|
BONDADA, SUBBARAO
|
UNIVERSITY OF KENTUCKY
|
KY
|
$381,420
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL126974-02
|
|
Fibrinogen and Factor XIII in Venous Thrombosis
|
WOLBERG, ALISA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$376,349
|
|
Hematology
|
2017
|
NHLBI
|
5K01HL116768-05
|
|
Atrial Fibrillation in Sepsis: Patient Outcomes and Provider Practice Patterns
|
WALKEY, ALLAN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$169,560
|
|
Hematology
|
2017
|
NCI
|
5R01CA030488-37
|
|
CONSTRUCTION AND ANALYSIS OF RETROVIRUS MUTANTS
|
GOFF, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$215,006
|
|
Hematology
|
2017
|
NCI
|
5R01CA203023-02
|
|
Biomarkers of Molecular Age to Predict the Toxicity of Cancer Chemotherapy
|
MUSS, HYMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$542,587
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL049413-21
|
|
Structural determinants of prothrombin activation
|
DI CERA, ENRICO
|
SAINT LOUIS UNIVERSITY
|
MO
|
$378,750
|
|
Hematology
|
2017
|
NCI
|
5R01CA075922-21
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$794,238
|
|
Hematology
|
2017
|
NCI
|
5R01CA174205-05
|
|
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
|
EKLUND, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$320,588
|
|
Hematology
|
2017
|
NIAID
|
5R01AI118305-03
|
|
MicroRNA Regulates Graft-versus-Host Disease
|
YU, XUE-ZHONG
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$371,988
|
|
Hematology
|
2017
|
NCI
|
5R01CA180813-04
|
|
Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs
|
GOTTWEIN, EVA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$320,588
|
|
Hematology
|
2017
|
NCI
|
5R01CA166144-06
|
|
Development of Therapeutic CD59 inhibitor for treating B-cell malignancies
|
QIN, XUEBIN
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$327,938
|
|
Hematology
|
2017
|
NCI
|
5R21CA183623-03
|
|
Pediatric Cancer Salvia Biorepository
|
GRAHAM, DAVID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$245,885
|
|
Hematology
|
2017
|
NCI
|
5R01CA193362-02
|
|
Role of integrin VLA-6 in suppression of bone formation in myeloma
|
YANG, JING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$370,179
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM113945-03
|
|
Hematopoietic Stem Cell Dysfunction in the Elderly after Severe Injury
|
EFRON, PHILIP
|
UNIVERSITY OF FLORIDA
|
FL
|
$300,000
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM114840-03
|
|
Muscle-mediated protection against MODS
|
YAN, ZHEN
|
UNIVERSITY OF VIRGINIA
|
VA
|
$300,200
|
|
Hematology
|
2017
|
NHLBI
|
2T32HL007150-41
|
|
Pediatric Hematology Research Training Program
|
PONCZ, MORTIMER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$288,463
|
|
Hematology
|
2017
|
NCI
|
5R01CA166054-05
|
|
Effect of anti-S phase agents on human chromosomes
|
DUTTA, ANINDYA
|
UNIVERSITY OF VIRGINIA
|
VA
|
$327,850
|
|
Hematology
|
2017
|
NIAID
|
5R01AI106676-04
|
|
Epstein Barr virus antisense transcription
|
FLEMINGTON, ERIK
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$376,250
|
|
Hematology
|
2017
|
NIAID
|
5R03AI123875-03
|
|
B1a Cell Function in Sickle Cell Disease
|
HOLODICK, NICHOL
|
WESTERN MICHIGAN UNIV SCHOOL OF MEDICINE
|
MI
|
$75,500
|
|
Hematology
|
2017
|
NHLBI
|
5R00HL118157-04
|
|
Regulation of Erythroid Terminal Differentiation by Long Noncoding RNAs
|
HU, WENQIAN
|
MAYO CLINIC ROCHESTER
|
MN
|
$249,000
|
|
Hematology
|
2017
|
NHLBI
|
5R00HL121076-04
|
|
Effect of diabetes on myelopoiesis and atherosclerosis
|
DUTTA, PARTHA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$244,474
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL130388-02
|
|
Improving the Availability of Younger Unrelated Hematopoietic Stem Cell Donors
|
SWITZER, GALEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$459,151
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK107807-02
|
|
Opiorphin as a master regulator of pathways leading to priapism
|
DAVIES, KELVIN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
NY
|
$488,475
|
|
Hematology
|
2017
|
NCI
|
5R01CA168482-05
|
|
HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma
|
MARTINEZ-MAZA, OTONIEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$319,550
|
|
Hematology
|
2017
|
NCI
|
5R01CA172106-06
|
|
Delta-like ligand 4+ dendritic cells and induction of alloimmunity
|
ZHANG, YI
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$323,700
|
|
Hematology
|
2017
|
NCI
|
5R01CA197422-02
|
|
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up
|
ZABLOTSKA, LYDIA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$680,242
|
|
Hematology
|
2017
|
NCI
|
5R01CA173636-05
|
|
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
|
LEVINE, ROSS
|
SLOAN-KETTERING INST CAN RESEARCH
|
NY
|
$639,626
|
|
Hematology
|
2017
|
NCI
|
5UM1CA173642-05
|
|
Women's Health Initiative Cancer Survivor Cohort
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$2,260,718
|
|
Hematology
|
2017
|
NIAID
|
5R01AI116993-03
|
|
Ultrarapid culture-independent detection of high-priority carbepenem resistant Enterobacteriaceae directly from blood
|
PRICE, CONNIE
|
DENVER HEALTH AND HOSPITAL AUTHORITY
|
CO
|
$914,354
|
|
Hematology
|
2017
|
NCI
|
5F30CA183497-04
|
|
Modeling Transformation: Myeloproliferative Neoplasms to Acute Myeloid Leukemia
|
MCKENNEY, ANNA
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$49,044
|
|
Hematology
|
2017
|
NCI
|
5R01CA091791-15
|
|
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$284,547
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK068634-12
|
|
Hematopoietic Regulation via GATA Switches
|
BRESNICK, EMERY
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$340,434
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM117028-02
|
|
Endothelial TAK1 Signaling and Resolution of Pulmonary Edema in Sepsis
|
TIRUPPATHI, CHINNASWAMY
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$319,800
|
|
Hematology
|
2017
|
NCI
|
2P30CA046934-29
|
5075
|
Hematologic Malignancies Program
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$52,680
|
|
Hematology
|
2017
|
NCI
|
5R01CA163800-06
|
|
Role of microRNAs in the regulation of CML stem cell self renewal and survival
|
PERROTTI, DANILO
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$264,526
|
|
Hematology
|
2017
|
NCI
|
5R01CA172268-05
|
|
The role of inhibitory receptors in leukemia development
|
ZHANG, CHENGCHENG
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$329,925
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK098812-04
|
|
The role of emergency granulopoiesis in the pathogenesis of Fanconi Anemia
|
EKLUND, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$336,038
|
|
Hematology
|
2017
|
NIDDK
|
5R01DK102791-03
|
|
Roles of Neogenin and Matriptase-2 in Hemojuvelin-Mediated Hepcidin Expression
|
ZHANG, AN-SHENG
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$332,264
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM105691-04
|
|
MegaTALS: hyperspecific reagents for targeted gene modification and correction
|
STODDARD, BARRY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$334,400
|
|
Hematology
|
2017
|
NIGMS
|
5R01GM100907-03
|
|
Molecular mechanism of chromatin targeting by BRPF1
|
KUTATELADZE, TATIANA
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$324,995
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL131143-02
|
|
Development of a gene therapy approach to treat acute lung injury using a preclinical, large animal model
|
DEAN, DAVID
|
UNIVERSITY OF ROCHESTER
|
NY
|
$776,235
|
|
Hematology
|
2017
|
NHLBI
|
2T32HL007062-41
|
|
Hematology Research Training Program
|
VERCELLOTTI, GREGORY
|
UNIVERSITY OF MINNESOTA
|
MN
|
$467,999
|
|
Hematology
|
2017
|
NIAID
|
5R01AI112579-03
|
|
Tcf/Lef-b-catenin in T cell identity and cancer
|
XUE, HAI-HUI
|
UNIVERSITY OF IOWA
|
IA
|
$381,250
|
|
Hematology
|
2017
|
NCI
|
5R01CA169116-06
|
|
Targeting IL-12/23 p40 Pathways for the Control of GVHD
|
YU, XUE-ZHONG
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$314,378
|
|
Hematology
|
2017
|
NCI
|
5R01CA201225-02
|
|
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
|
ARMISTEAD, PAUL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$500,397
|
|
Hematology
|
2017
|
NCI
|
5R01CA184185-04
|
|
Stress Pathways in Tumors Drive Global MDSC Activity and Survival through Chop
|
RODRIGUEZ, PAULO
|
AUGUSTA UNIVERSITY
|
GA
|
$137,679
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL116472-05
|
|
Regulation of Innate Immunity by F-Box Proteins
|
CHEN, BEIBEI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$385,000
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL120948-04
|
|
Functional phenotyping of human genetic variation
|
MONNAT, RAYMOND
|
UNIVERSITY OF WASHINGTON
|
WA
|
$386,250
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL120922-04
|
|
The role of nucleases in interstrand crosslink repair
|
SMOGORZEWSKA, AGATA
|
ROCKEFELLER UNIVERSITY
|
NY
|
$423,750
|
|
Hematology
|
2017
|
NHLBI
|
5R01HL121212-04
|
|
Heteromultivalent Peptide-Lipid Nanoconstructs as Artificial Platelet Analogs
|
SEN GUPTA, ANIRBAN
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$386,166
|
|
Hematology
|
2017
|
NINDS
|
5U01NS079077-05
|
|
Insights on Selected Procoagulation Markers and Outcomes in Stroke Trial (I-SPOT)
|
GENTILE, NINA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$393,724
|
|
Hematology
|
2017
|
NHLBI
|
1T35HL134624-01
|
|
UNC-CH ISTEM Program
|
BRICE, JANE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$44,673
|
|
Hematology
|
2017
|
NHLBI
|
2T32HL007974-16
|
|
Immunohematology/Transfusion Medicine Research Training
|
SMITH, BRIAN
|
YALE UNIVERSITY
|
CT
|
$471,109
|
|
Hematology
|
2017
|
NCI
|
2P30CA006516-52
|
5399
|
Program 4: Leukemia
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$43,922
|
|
Hematology
|
2017
|
NCI
|
2P30CA006516-52
|
5400
|
Program 6: Lymphoma and Myeloma
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INST
|
MA
|
$43,077
|
|
Hematology
|
2017
|
NCI
|
2P30CA006516-52
|
5409
|
Program 30: Neuro-Oncology
|
STILES, CHARLES
|
DANA-FARBER CANCER INST
|
MA
|
$42,805
|
|
Hematology
|
2017
|
NIAID
|
1P01AI127335-01
|
5414
|
Administrative Core
|
NELSON, JAY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$107,017
|
|
Hematology
|
2017
|
NIAID
|
1P01AI127335-01
|
5415
|
Humanized Mouse Core
|
CAPOSIO, PATRIZIA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$300,233
|
|
Hematology
|
2017
|
NIAID
|
1P01AI127335-01
|
5416
|
Genomics, Biostatistics and Bioinformatics Core
|
MCWEENEY, SHANNON
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$240,815
|
|
Hematology
|
2017
|
NIAID
|
1P01AI127335-01
|
5417
|
HCMV UL133/8 regulation of host cell signaling in viral latency and hematopoiesis
|
GOODRUM, FELICIA
|
UNIVERSITY OF ARIZONA
|
AZ
|
$272,250
|
|
Hematology
|
2017
|
NIAID
|
1P01AI127335-01
|
5418
|
HCMV miRNA regulation of host cell signaling in viral latency and hematopoiesis
|
NELSON, JAY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$305,312
|
|
Hematology
|
2017
|
NIAID
|
1P01AI127335-01
|
5419
|
HCMV US28 regulation of host cell signaling in viral latency and hematopoiesis
|
STREBLOW, DANIEL
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$289,591
|
|
Hematology
|
2017
|
NIAID
|
1P01AI127335-01
|
5420
|
HCMV UL7 regulation of host cell signaling in viral latency and hematopoiesis
|
CAPOSIO, PATRIZIA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$288,625
|
|
Hematology
|
2017
|
NIAID
|
1P01AI127335-01
|
5421
|
HCMV regulation of host cell signaling and cytokines in myelosuppression
|
YUROCHKO, ANDREW
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
LA
|
$196,157
|
|
Hematology
|
2017
|
NHLBI
|
2T35HL074708-11
|
|
Training Students in Biomedical Research in Hematology
|
RAGNI, MARGARET
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$25,240
|
|
Hematology
|
2017
|
NIBIB
|
1R03EB023190-01
|
|
Development of a Point of Care Multiplexed Diagnostic Platform to Target Anemia and Micronutrient Deficiencies
|
FINKELSTEIN, JULIA
|
CORNELL UNIVERSITY
|
NY
|
$113,080
|
|
